HBOT Application in Erectile Dysfunction (HBOTED)
Hyperbaric Oxygen Can Improve Erectile Dysfunction and Induce Penile Angiogenesis
Sponsor: Assaf-Harofeh Medical Center
Listed as NCT02619383, this PHASE1 trial focuses on Erectile Dysfunction and Hyperbaric Oxygen Therapy and remains completed. Sponsored by Assaf-Harofeh Medical Center, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assaf-Harofeh Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .